Cargando…

Evidence for using a dual COX 1/2 and 5-LOX inhibitor in neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Irrera, Natasha, Bitto, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558485/ https://www.ncbi.nlm.nih.gov/pubmed/28852388 http://dx.doi.org/10.4103/1673-5374.211185

Ejemplares similares

Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
por: Bitto, Alessandra, et al.
Publicado: (2012)

Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
por: Bitto, Alessandra, et al.
Publicado: (2023)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor
por: Athira, A. P., et al.
Publicado: (2013)

Synthesis, Evaluation of Enzyme Inhibition and Redox Properties of Potential Dual COX-2 and 5-LOX Inhibitors
por: Bošković, Jelena, et al.
Publicado: (2023)

Biological Evaluation of Naproxen–Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors
por: Moreira, Rute, et al.
Publicado: (2020)

Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors
por: El-Miligy, Mostafa M. M., et al.
Publicado: (2022)

Dual COX and 5-LOX inhibition by clerodane diterpenes from seeds of Polyalthia longifolia (Sonn.) Thwaites
por: Nguyen, Ha Thi, et al.
Publicado: (2020)

The Medicinal Timber Canarium patentinervium Miq. (Burseraceae Kunth.) Is an Anti-Inflammatory Bioresource of Dual Inhibitors of Cyclooxygenase (COX) and 5-Lipoxygenase (5-LOX)
por: Mogana, R., et al.
Publicado: (2013)

Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations
por: Thiel, Christoph, et al.
Publicado: (2018)

A Metabolomic Approach to Target Compounds from the Asteraceae Family for Dual COX and LOX Inhibition
por: Chagas-Paula, Daniela A., et al.
Publicado: (2015)

Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
por: Mannino, Federica, et al.
Publicado: (2020)

Expression of COX-1, COX-2, 5-LOX and [Formula: see text] in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease
por: Vorsprach, Monique, et al.
Publicado: (2019)

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2015)

Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study
por: Chlapek, Petr, et al.
Publicado: (2010)

The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression
por: Chlapek, Petr, et al.
Publicado: (2014)

Synthesis, Biological, Spectroscopic and Computational Investigations of Novel N-Acylhydrazone Derivatives of Pyrrolo[3,4-d]pyridazinone as Dual COX/LOX Inhibitors
por: Mikus, Jakub, et al.
Publicado: (2023)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Modulation of Cox-1, 5-, 12- and 15-Lox by Popular Herbal Remedies Used in Southern Italy Against Psoriasis and Other Skin Diseases
por: Bader, Ammar, et al.
Publicado: (2015)

In Vitro and In Silico Investigation of Polyacetylenes from Launaea capitata (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors
por: Abdel Bar, Fatma M., et al.
Publicado: (2023)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

COX-2 in the neurodegenerative process of Parkinson's disease
por: Teismann, Peter
Publicado: (2012)

Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives
por: Silveira, Gustavo de Bem, et al.
Publicado: (2021)

Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
por: Chepke, Craig, et al.
Publicado: (2021)

Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies
por: Rudrapal, Mithun, et al.
Publicado: (2023)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
por: Burnett, Bruce P., et al.
Publicado: (2011)

Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models
por: Tomioka, Ikuo, et al.
Publicado: (2018)

Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
por: Lauro, Rita, et al.
Publicado: (2021)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a9ai95g1cafq7qbv2ijre4l30d